Clinical trial · Observational
Early Detection of Prostate Cancer of Syrian Men
Early Detection of Prostate Cancer Among Men in the Middle Region of Syria
NCT07075666CI-TRIAL-00092363enrolling by invitationClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Prostate cancer is a significant health concern in the Middle East, including Syria, where many cases are diagnosed at advanced stages due to low awareness and inadequate screening practices. The mortality-to-incidence ratio for prostate cancer in the region is alarmingly high, indicating a pressing need for effective early detection strategies.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| the Detection of Prostate Cancer in Men | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| DRE | Diagnostic Test | — | UNRESOLVED |
| PSA | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Number of ptients with early signs of prostate cancer
- timeFrame
- From Participant enrolment to the end of the study at 2 weeks
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 40 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Men aged 40 years and older residing in the middle region of Syria. Exclusion Criteria: * Men with a previous diagnosis of prostate cancer.
References
Publications (0)
Data not yet available
No reference posted for this study.